ArticleBiology of sport2026
Prevalence, implementation, and barriers of sodium bicarbonate supplementation in team sports.
Article in Biology of sport, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Sodium bicarbonate (SB) ingestion has empirical evidence supporting its efficacy for improving team sport performance. It is currently unclear, however, if SB is incorporated into nutritional regimes by practitioners. This study aimed to investigate existing prevalence, implementation, and barriers of SB supplementation in team sports. A cross-sectional, observational design was employed. In total, 66 practitioners (professional experience: 7 ± 5 years) based in UK or USA responded to an online survey. Most practitioners (n = 60; 91%) were aware of SB being used as an ergogenic aid, which was predominately attributed to reputable sources (e.g., scientific literature: n = 35; 58%). Prevalence rates were low (n = 20; 33%), with a significant difference between the frequency of responses for practitioners who use SB (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.